Dramatic response to immunotherapy in an epidermal growth factor receptor-mutant non-small cell lung cancer: A case report
Ding Li(Henan Cancer Hospital), Xuan Wu(Zhengzhou University), Peizan Ni(Zhengzhou University), Cheng Cheng(Jilin University), Wenzhou Zhang(Zhengzhou University), Wenping Song(Henan Cancer Hospital)
Cited by 3
Related Papers
MEK inhibitors for the treatment of non-small cell lung cancer
|Journal of Hematology & Oncology|2021|300
<i>TP53</i> Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children
|Journal of Clinical Oncology|2018|179
New Frontiers in Osteoporosis Therapy
|Annual Review of Medicine|2019|141
Hemophagocytic lymphohistiocytosis‐like toxicity (carHLH) after CD19‐specific CAR T‐cell therapy
|British Journal of Haematology|2021|122